Maharashtra, India

Raghu Prasad Mailavaram


Average Co-Inventor Count = 6.4

ph-index = 1


Location History:

  • Maharashtra, IN (2024)
  • Dhule, IN (2024)

Company Filing History:


Years Active: 2024-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Raghu Prasad Mailavaram

Introduction

Raghu Prasad Mailavaram is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory and antimicrobial agents. With a total of five patents to his name, his work has the potential to impact medical treatments significantly.

Latest Patents

Mailavaram's latest patents include innovative compounds such as selective COX-2 inhibitors, specifically 2-(substituted benzyl)-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-4-ones and 4-fluoro-N-(4-oxo-3,5,6,7-tetrahydro-4H-cyclopenta[4,5]thieno[2,3-d]pyrimidin-2-yl)benzamide. These compounds are recognized for their utility as anti-inflammatory agents. Additionally, he has developed 3-cyano 4,5-diphenyl furan-2-carboxamides, which serve as antitubercular agents, providing new avenues for treating microbial infections and tuberculosis.

Career Highlights

Mailavaram is associated with King Fahd University of Petroleum and Minerals, where he continues to advance his research and innovation in the pharmaceutical field. His work is characterized by a strong focus on developing compounds that address significant health challenges.

Collaborations

Some of his notable coworkers include Katharigatta N Venugopala and Pran Kishore Deb. Their collaborative efforts contribute to the advancement of research and innovation in their respective fields.

Conclusion

Raghu Prasad Mailavaram's contributions to pharmaceutical innovations highlight his role as a significant inventor in the industry. His patents reflect a commitment to developing effective treatments for inflammatory and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…